|
CACYBP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.519050E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.095600E-03 |
| Normal-vs-Stage2 |
1.698710E-03 |
| Normal-vs-Stage3 |
5.759100E-03 |
| Normal-vs-Stage4 |
3.309600E-02 |
| Stage1-vs-Stage2 |
5.041800E-01 |
| Stage1-vs-Stage3 |
6.531400E-01 |
| Stage1-vs-Stage4 |
1.428200E-01 |
| Stage2-vs-Stage3 |
3.978600E-01 |
| Stage2-vs-Stage4 |
1.217010E-01 |
| Stage3-vs-Stage4 |
4.022800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.640800E-04 |
| Normal-vs-AfricanAmerican |
5.675800E-01 |
| Normal-vs-Asian |
5.519800E-02 |
| Caucasian-vs-AfricanAmerican |
4.280900E-03 |
| Caucasian-vs-Asian |
7.547700E-02 |
| AfricanAmerican-vs-Asian |
2.689200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.738240E-03 |
| Normal-vs-Female |
1.898880E-03 |
| Male-vs-Female |
6.916800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.104430E-03 |
| Normal-vs-Age(41-60Yrs) |
1.495630E-03 |
| Normal-vs-Age(61-80Yrs) |
5.275400E-03 |
| Normal-vs-Age(81-100Yrs) |
6.819000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.781000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.255200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.243800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.092800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.589850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.591200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.599200E-01 |
| Classical-VS-Follicular |
1.8069199999915E-05 |
| Classical-VS-Other |
5.675600E-01 |
| Classical-VS-Normal |
1.106450E-02 |
| Tall-VS-Follicular |
4.641700E-02 |
| Tall-VS-Other |
7.918000E-01 |
| Tall-VS-Normal |
3.975800E-02 |
| Follicular-VS-Other |
4.150000E-01 |
| Follicular-VS-Normal |
1.77018999999445E-05 |
| Other-VS-Normal |
1.784390E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.378800E-04 |
| Normal-vs-N1 |
1.121140E-03 |
| N0-vs-N1 |
8.906600E-01 |
|
|
